5.67
-0.18 (-3.08%)
| Previous Close | 5.85 |
| Volume | 668,877 |
| Price / Earnings (Forward) | 15.24 |
| Price / Sales | 3.51 |
| 52 Weeks Range |
| Profit Margin | 16.42% |
| Operating Margin (TTM) | 7.97% |
| Diluted EPS (TTM) | 0.370 |
| Quarterly Revenue Growth (YOY) | 260.00% |
| Quarterly Earnings Growth (YOY) | -65.50% |
| Current Ratio (MRQ) | 1.73 |
| Operating Cash Flow (TTM) | -148.89 M |
| Levered Free Cash Flow (TTM) | -216.76 M |
| Return on Assets (TTM) | 7.02% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Mixed |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Mixed | |
| Stock | Alvotech | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 4.0 |
| Average | 2.00 |
|
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Growth |
| % Held by Insiders | 63.44% |
| % Held by Institutions | 6.44% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |